SLS · SELLAS Life Sciences Group, Inc. · Share Buybacks
$11.40
+0.14 (+1.24%)
At close · Oct 9
Return incl. dividend (before tax)
Market Cap
$2.27B
Shares
201.95M
Volume · Oct 8
4.21M
Avg daily vol (3M)
6.53M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2026-03 | — | $150,000,000 | — | — | 10-Q , filed 2026-08-11 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2010-12-31 | $3,849,000 | 10-K, filed 2012-03-28 |
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
11 filings
11 filers
Visit website
Investor relations